AbbVie Inc Share Price Today: Live Updates & Key Insights
AbbVie Inc share price today is $205.99, up -0.56%. The stock opened at $206.265 against the previous close of $206.23, with an intraday high of $207.78 and low of $203.08.
AbbVie Inc Share Price Chart
AbbVie Inc Share Price Performance
AbbVie Inc Institutional Holdings
AbbVie Inc Market Status
AbbVie Inc Fundamentals
Market Cap 362598.43 M
PB Ratio 50.4573
PE Ratio 86.1639
Enterprise Value 426888.50 M
Total Assets 133960.00 M
Volume 27982356
AbbVie Inc Company Financials
About AbbVie Inc & investment objective
Company Information AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Organisation Drug Manufacturers - General
Employees 57000
Industry Drug Manufacturers - General
CEO Mr. Robert A. Michael CPA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
AbbVie Inc FAQs
What is the share price of AbbVie Inc today?
The current share price of AbbVie Inc is $205.99.
Can I buy AbbVie Inc shares in India?
Yes, Indian investors can buy AbbVie Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy AbbVie Inc shares in India?
You can easily invest in AbbVie Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy AbbVie Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of AbbVie Inc.
Can I buy fractional shares of AbbVie Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of AbbVie Inc?
AbbVie Inc has a market cap of $362598.43 M.
In which sector does AbbVie Inc belong?
AbbVie Inc operates in the Drug Manufacturers - General sector.
What documents are required to invest in AbbVie Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of AbbVie Inc?
The PE ratio of AbbVie Inc is 86.16 and the PB ratio is 50.46.